NEU neuren pharmaceuticals limited

Ann: DAYBUE (trofinetide) launched in US - Neuren earns US$40m, page-22

  1. 128 Posts.
    lightbulb Created with Sketch. 25
    An amazing turning point! Thank you for wording it this way.

    I can see that there may be another period of consolidation and support until the next milestone / announcement, but today represents the start of recurring revenue and real value to those who have waited for years for this life changing treatment.

    More details coming surely, on the uptake amongst the rett population, and nz 2591 too.

    i dont see any reason to "dump" or sell. If anything, long term holders might choose to manage risk due to their (now) large NEU holdings, which they have every right to do and may even feel some hesitation in doing so...
    Last edited by ImpetuousLady: 18/04/23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.81
Change
1.270(10.1%)
Mkt cap ! $1.729B
Open High Low Value Volume
$12.96 $14.00 $12.91 $12.76M 929.8K

Buyers (Bids)

No. Vol. Price($)
6 743 $13.80
 

Sellers (Offers)

Price($) Vol. No.
$13.81 285 3
View Market Depth
Last trade - 14.28pm 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.